| 18 years and more
- | Country :
- France
- | organs :
- Prostate
- | Specialty :
- Radiothérapie
- Thérapies Ciblées
Extract
A randomized, double-blind, phase 3 trial comparing ipilimumab vs. placebo following radiotherapy in subjects with castration resistant prostate cancer that have received prior treatment with docetaxel.
Scientific Abstract
en cours d'intégration;